By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



The Dow Chemical Company
574 Building
Midland  Michigan  48667  U.S.A.
Phone: 866-332-5805 Fax: 989-636-0986

Dowpharma, a business unit within Dow, serves the pharmaceutical and biopharmaceutical industries with innovative technology, products, and services for clients in drug discovery, development, manufacturing, and delivery. Dowpharma combines the resources and capabilities of several offerings to create a single, market-focused organization with broad service and support capabilities for large and emerging pharmaceutical companies.

Dowpharma services include process development, route selection, methods development, custom solubilization, including BioAqueous solubilization services; chiral capabilities, and associated analytical services; biotargeted radiopharmaceuticals development through ChelaMed radiopharmaceutical services as well as manufacturing and scale-up from feasibility, through clinical trials, to commercial manufacturing. Dowpharma currently manufactures small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, nucleic acid medicines, cGMP polymers, peptides and therapeutic proteins from microbial fermentation, including Pfēnex Expression Technology, a Pseudomonas-based system, and plant-based systems.

Dowpharma draws upon over 30 years of excellent cGMP regulatory compliance in the organic synthesis of APIs and pharmaceutical intermediates with the ability to provide client support in filing and validation strategies. Dowpharma operates research, process development, and manufacturing facilities in North America and Europe.

Last Updated: 07-12-05

Key Statistics

Ownership: Public

Web Site: Dowpharma
Employees: 43,000
Symbol: DOW


Cytogen Corporation  License to Quadramet

Company News
Dowpharma (DOW) Release: Performance Plastics Division Created 3/1/2011 1:59:45 PM
India's Dr. Reddy's Laboratories Ltd. (RDY)'s Says to Buy Dowpharma (DOW) Units 4/1/2008 6:42:37 AM
VGX Pharmaceuticals (Formerly Known as Viral Geno And Dowpharma (DOW) Sign Research And Development Agreement For VGX Pharmaceuticals (Formerly Known as Viral Geno's Lead Cancer Compound 2/28/2006 5:52:11 PM
Viventia Biotech Inc. (VBI.TO) And Dowpharma (DOW)(SM) Announce A Multi-Product Commercial License Agreement Using Pfenex Expression Technology(TM) From Dowpharma (DOW) 2/14/2006 2:31:16 PM
Cambrex Corporation (CBM) Named First Biopharmaceutical Manufacturing Partner For Pfenex Expression Technology(TM) From Dowpharma (DOW) 12/20/2005 10:32:15 AM
Alnylam Pharmaceuticals (ALNY) Announces Manufacturing Agreement With Dowpharma (DOW) For RNAi Therapeutics10/19/2005 5:13:09 PM
Dowpharma (DOW) Announces Agreement With Pfizer Inc. (PFE) Using Pfenex Expression Technology(TM) And Dow Solvent Extraction Technology10/19/2005 5:12:56 PM
Locus Pharmaceuticals, Inc. Initiates Research Collaboration With Dow Agrosciences10/19/2005 5:12:13 PM
The Dow Chemical Company (DOW) And University of Texas Austin Extend R&D Collaboration For Drug Solubilization Based On Advanced Particle Engineering10/19/2005 5:12:03 PM
Kereos, Inc. And Dow Chemical Company (DOW) Sign Licensing Agreement For Novel Targeted Imaging Agents10/19/2005 5:11:36 PM